Navigation Links
PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting
Date:12/6/2007

nd

thrombovascular events, use the lowest dose needed to avoid red blood

cell transfusions.

-- Use only for treatment of anemia due to concomitant myelosuppressive

chemotherapy.

-- Discontinue following the completion of a chemotherapy course.

Perisurgery: PROCRIT increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis.

Contraindications

PROCRIT is contraindicated in patients with uncontrolled hypertension or with known hypersensitivity to albumin (human) or mammalian cell-derived products.

Additional Important Safety Information

-- The dose of PROCRIT should be titrated for each patient to achieve and

maintain the following hemoglobin levels:

-- Chronic renal failure patients -- hemoglobin levels between 10

to 12 g/dL. If a patient does not attain hemoglobin levels of 10

to 12 g/dL despite 12 weeks of appropriate PROCRIT therapy, see

DOSAGE and ADMINISTRATION in the PROCRIT Prescribing

Information.

-- Cancer or HIV patients -- the lowest hemoglobin level sufficient

to avoid transfusion and not to exceed 12 g/dL.

-- Monitor hemoglobin regularly during therapy, more frequently

following a dosage adjustment or until hemoglobin becomes stable.

-- Cases of pure red cell aplasia (PRCA) and of severe anemia, with

or without other cytopenias, associated with neutralizing antibodies to

erythropoietin have been reported in patients with chronic renal

failure receiving PROCRIT by subcutaneous administration. If any

patient develops a sudden loss of response to PROCRIT, accompanied by

severe anemia and low reticulocyte count, and anti-erythropoietin

antibody-associated anemia is suspected, withhold PROCRIT and other


'/>"/>

SOURCE Ortho Biotech
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
2. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
8. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... IRVINE, Calif., Aug. 4, 2015  Syneron Medical Ltd. (NASDAQ: ... announced financial results for the three month period ended June ... Recent Non-GAAP 1 Highlights: , ... constant currency. , North American product sales grew 45% ... in constant currency, including 14% product growth in the EMEA ...
(Date:8/3/2015)...   The Intellectual Property and Science business ... of intelligent information for businesses and professionals announced ... R&D Factbook , the biopharmaceutical industry,s leading resource ... in R&D, the analysis identifies a surge in ... forecasts sales to reach $1.3 trillion by 2018. ...
(Date:8/3/2015)... GLENWOOD, Ill. , Aug. 3, 2015  Landauer, ... personal and environmental radiation measurement and monitoring, outsourced medical ... announced it will release financial results for the fiscal ... August 10, 2015. The Company will ... August 11, 2015 at 9:00 a.m. Central Time (10:00 ...
Breaking Medicine Technology:Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Pharma Sales to Grow Beyond $1 Trillion 2Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2
... Feb. 1, 2011 Anthera Pharmaceuticals, Inc. (Nasdaq: ... treat serious diseases associated with abnormal auto-immune responses and ... Thompson to its Board of Directors. Currently, Dr. Thompson ... founder and Managing Director of Strategicon Partners, an investment ...
...  China Medicine Corporation (OTC Bulletin Board: ... and distributor of Western pharmaceuticals, traditional Chinese medicines ... Republic of China, today announced that the Company ... Ministry of Agriculture ("MOA") for the Company,s proprietary ...
Cached Medicine Technology:Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors 2China Medicine Corporation Receives Manufacturing License for rADTZ 2China Medicine Corporation Receives Manufacturing License for rADTZ 3
(Date:8/4/2015)... ... , ... assistPoint Partners, LLC is proud to announce ... programs. Through a secure web portal, assistPoint connects Life Sciences, Patients and Providers ... application and workflow solution. This provides cancer center patient advocates, financial counselors and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Rhode Island Medical Imaging (RIMI) is ... Washington Medical Building on Wake Robin Road in Lincoln, RI. This satellite office ... offer the most extensive out-patient x-ray hours in the state, which includes evenings and ...
(Date:8/4/2015)... Angeles, CA (PRWEB) , ... August 04, 2015 , ... ... study that found financial incentives to be a viable method for encouraging people to ... wager money on the future of their weight loss success, adding a financial incentive ...
(Date:8/4/2015)... ... August 04, 2015 , ... Angelina Jolie is in it at age ... every year. Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” ... scary unknown out of menopause. , Myth #1: Menopause only affects old ladies. ...
(Date:8/4/2015)... Texas (PRWEB) , ... August 04, 2015 , ... ... in the industry. , Worldwide Power Products is expanding its reach in Texas. ... of the Alpine Power Systems North Texas generator division. With the North ...
Breaking Medicine News(10 mins):Health News:assistPoint.com Web Site Launched 2Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:North Texas Acquisition Press Release 2
... ... Name, and the nation,s largest and most effective Accelerated Flight Training Organizations in the ... Equipped With the New Perspective Avionics by Garmin. , ... Newport Beach, CA (PRWEB) June 24, 2009 -- ...
... approval in Q4-2009 , , SEATTLE, June 24 ... that it has completed the submission of the New Drug ... for pixantrone to treat relapsed or refractory, aggressive non-Hodgkin,s lymphoma ... to an approval decision from the FDA in the fourth ...
... , MEMPHIS, Tenn., June 24 The Theraplex Company, makers ... theraplex SA FACIAL PEEL last week at the ... of excitement among dermatologists attending the camp. , , ... treatment available in 25% and 30% concentrations. This versatile skin ...
... Businesses Support Private Insurance Over Federal Plan, Oppose Mandates , ... ready for major changes to the American health care system, ... to help them cope with the costs. When asked for ... micro-business owners cited cost containment, even over access and choice. ...
... the poor prognosis in some breast cancer cases. A ... BMC Medical Genomics , suggests that some estrogen receptor-positive ... GF signaling. Sherene Loi, from the Peter MacCallum ... and Belgian researchers to investigate the differences between those ...
... cancer, experts say, , TUESDAY, June 23 (HealthDay News) -- ... of developing cancer, but there appears to be no such ... with an increased risk of developing many different cancers. In ... cancer deaths in men and 20 percent of such deaths ...
Cached Medicine News:Health News:AFIT Accelerated Flight & Instrument Training Announces New Accelerated Flight Training Programs For Cirrus Aircraft Equipped With New Perspective Avionics by Garmin (CSIP) 2Health News:AFIT Accelerated Flight & Instrument Training Announces New Accelerated Flight Training Programs For Cirrus Aircraft Equipped With New Perspective Avionics by Garmin (CSIP) 3Health News:Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 2Health News:Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 3Health News:Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 4Health News:New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 2Health News:Micro-Businesses Offer Strong Opinions On Health Reform Proposals 2Health News:Micro-Businesses Offer Strong Opinions On Health Reform Proposals 3Health News:Micro-Businesses Offer Strong Opinions On Health Reform Proposals 4Health News:A new take on growth factor signaling in tamoxifen resistance 2Health News:Bariatric Surgery Cuts Cancer Risk for Women 2Health News:Bariatric Surgery Cuts Cancer Risk for Women 3
... Tupper's Universal Hand Holder and ... fixate the hand in any position ... with skin or tendon hooks, fixate ... Holder. With the patient's hand held ...
Stryker Instruments, the leader in cordless power, advances orthopaedics with the power, speed, versatility, reliability and performance through its heavy duty powered instruments....
... iso-centered c-arm with its integrated ... to position in the sterile ... x-ray tube head, three position ... control provide convenient access to ...
... The SmartPLUG from Medennium is ... the "punctum" or tear duct, and ... is designed to fit a range ... flexible thermosensitive acrylic material, SmartPLUG adjusts ...
Medicine Products: